Keys to development of treatment resistance in melanoma found in SU2C-supported research - Stand Up To Cancer

Give Now

News

Keys to development of treatment resistance in melanoma found in SU2C-supported research

A research team led by Roger S. Lo, MD, PhD, of the University of California at Los Angeles (UCLA), has tracked the changes in advanced melanomas that become resistant to some of the new targeted therapies, in the hopes of finding out how drug resistance occurs. In 2011, Dr. Lo received the Allan H. “Bud” and Sue Selig SU2C Melanoma IRG, named after the former commissioner of Major League Baseball and his wife, who have been major supporters of SU2C.

JOIN OUR COMMUNITY

Sign up to receive emails from Stand Up To Cancer.
   Please leave this field empty
Stand Up to Cancer

Thanks for signing up!
You will hear from us soon.